EUVIMEDEUVIMED entdecken
Leserbrief

Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response

Murat Türk iD, İnsu Yılmaz iD, Ragıp Ertaş, Emek Kocatürk

Allergy · 2025-08 · 80 (8) · 2410-2413

DOI: 10.1111/all.16670 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Allergy, online erschienen am 18.07.2025. Verfasst von Murat Türk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

allergy treamentbiologicsdermatologypersonalized medicineurticaria

Autor:innen und Institutionen

  • Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye.
  • Department of Dermatology, Kayseri City Education and Research Hospital, University of Health Sciences, Kayseri, Türkiye.
  • Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Department of Dermatology, School of Medicine, Bahçeşehir University, Istanbul, Türkiye.

ORCID-Profile: Murat Türk, İnsu Yılmaz

Zitieren

APA

Türk, M., Yılmaz, İ., Ertaş, R., & Kocatürk, E. (2025). Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response. Allergy, 80(8), 2410-2413. https://doi.org/10.1111/all.16670

Vancouver

Türk M, Yılmaz İ, Ertaş R, Kocatürk E. Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response. Allergy. 2025;80(8):2410-2413. doi:10.1111/all.16670

BibTeX
@article{Trk2025,
  author = {Türk, Murat and Yılmaz, İnsu and Ertaş, Ragıp and Kocatürk, Emek},
  title = {Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {8},
  pages = {2410--2413},
  doi = {10.1111/all.16670}
}
Kostenlos starten →